Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
enzalutamide (xtandi) (1 trial)
Ga 68 PSMA-11 (Illuccix) (1 trial)
taselisib (1 trial)
tremelimumab (Imjudo) (1 trial)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 1)
Carcinoma, Renal Cell (Phase 1)
Trials (3 total)
Trial APIs (4 total)